IDH2 and cancer: Although IDH mutations had been reported to promote cell proliferation in many types of cancer cells as a basal oncogenic activity [4], other studies also showed contradictory results of reduced cell growth induced by IDH mutations or 2-HG [23–25], suggesting that the effect of IDH mutants on cell proliferation is dependent on the type of cells.